Johnson & Johnson MedTech, a US-based healthcare giant, announced the official launch of its HARMONIC 7s ultrasonic scalpel instrument in China, marking a milestone with local production at its Suzhou plant.
Product Highlights
The HARMONIC 7s features an innovative built-in intelligent chip and proprietary next-generation adaptive tissue algorithm (ATT), enabling continuous intelligent energy delivery during surgery. Its advanced hemostasis mode can occlude blood vessels up to 7 millimeters, enhancing surgical agility and efficiency.
Market Impact
Since entering China, J&J’s HARMONIC series has benefited tens of millions of patients. The local production of the 7s model underscores the company’s commitment to meeting the evolving surgical needs of the Chinese market.-Fineline Info & Tech
